Strategic Growth

OSD- Rising - Reach 855m by march 2027

This effort is 52% complete, standing at 400 of 1200. It moves through 3 workstreams.

• Current volume is 46% of the way there — 550 Million of 1200 Million, marked On track.

• No.of ANDAs is 62% of the way there — 40 of 65, marked On track.

• Capex is 47% of the way there — 700 Million of 1500 Million, marked On track.

Graviti - Branded generics - US Entry

This effort is 0% complete. It moves through 2 workstreams.

• Operational licenses is 0% of the way there — 0 of 55, marked On track.

• Build team is 0% of the way there, marked On track.

  • President is 0% of the way there — 0 of 1, marked On track.

  • Sales Head is 0% of the way there — 0 of 1, marked On track.

Filing 20 Products

This effort is 5% complete, standing at 1 of 20.

5 in pipeline

establishing companies

This effort is 0% complete, standing at 0 of 2.

B2B Deals

This effort is 0% complete.

Build teams

This effort is 0% complete.

Number of Products to be extended

This effort is 0% complete.

countries to enter

This effort is 0% complete.

Current status

This effort is 14% complete, standing at from 3.5, 2.7 of 2. It moves through 2 workstreams.

• Savings in time (efficiency improvement, process streamlining, automation projects) is 21% of the way there — from 0 Hrs, 810 Hrs of 3839 Hrs, marked On track.

• Savings in Lakhs is 6% of the way there — from 0, 10.5 of 187, marked On track.

Develop own API

This effort is 50% complete, standing at from 0, 5 of 10.

Price negotiations

This effort is 0% complete.

TO be updated with averages across

Current Product development goals

This effort is 27% complete. It moves through 2 workstreams.

• 19 products in 2026 is 53% of the way there — 10 of 19, marked On track.

• 50 products by 2027 is 0% of the way there — 0 of 50, marked On track.

Future portfolio expansion (products to be put in development cycle)

This effort is 0% complete. It moves through 3 workstreams.

• Simple products development is 0% of the way there — 0 of 4, marked On track.

  All ongoing

• Injectables to be developed is 0% of the way there — 0 of 5, marked On track.

• Complex generics is 0% of the way there — 0 of 10, marked On track.

Land Allocation

This effort is 0% complete.

API Portfolio

This effort is 50% complete, standing at 5 of 10.

out of 5 3 are commercial and 2 are DMF filed. 3 in pipeline

OSD Unit 2

This effort is 0% complete.

API Unit 1

This effort is 0% complete.